All News about Aim Immunotech IncVia Benzinga
AIM ImmunoTech Receives Positive FDA Response For Ampligen Trial In PCCD Patients
September 21, 2021
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|